Literature DB >> 33787349

Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections.

Swee Li Ng1, Kooi-Yeong Khaw1, Yong Sze Ong1, Hui Poh Goh2, Nurolaini Kifli2, Siew Phooi Teh1,3, Long Chiau Ming2, Vijay Kotra4, Bey Hing Goh1,3.   

Abstract

The management of the global pandemic outbreak due to the coronavirus disease (COVID-19) has been challenging with no exact dedicated treatment nor established vaccines at the beginning of the pandemic. Nonetheless, the situation seems to be better controlled with the recent COVID-19 vaccines roll-out globally as active immunisation to prevent COVID-19. The extensive usage and trials done in recent outbreak in China has shown the effectiveness of traditional Chinese Medicines (TCM) in improving the wellbeing of COVID-19 patients. Therefore, COVID-19 Prevention and Treatment guidelines has listed a number of recommended concoctions meant for COVID-19 patients. Licorice, more commonly known as Gancao in Chinese Pinyin, is known as one of the most frequently used ingredients in TCM prescriptions for treatment of epidemic diseases. Interestingly, it is deemed as food ingredient as well, where it is normally used in Western cuisines' desserts and sweets. The surprising fact that licorice appeared in the top 10 main ingredients used in TCM prescriptions in COVID-19 has drawn great attention from researchers in revealing its biological potential in overcoming this disease. To date, there are no comprehensive review on licorice and its benefits when used in COVID-19. Thus, in this current review, the possible benefits, mechanism of actions, safety and limitations of licorice were explored in hope to provide a quick reference guide for its preclinical and clinical experimental set-up in this very critical moment of pandemic.

Entities:  

Keywords:  COVID-19; Glycyrrhizae; SARS-CoV-2; anti-viral; licorice

Mesh:

Substances:

Year:  2021        PMID: 33787349     DOI: 10.1177/2515690X21996662

Source DB:  PubMed          Journal:  J Evid Based Integr Med        ISSN: 2515-690X


  7 in total

Review 1.  Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.

Authors:  Mohitosh Biswas; Nares Sawajan; Thanyada Rungrotmongkol; Kamonpan Sanachai; Maliheh Ershadian; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

2.  The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.

Authors:  Mya Myat Ngwe Tun; Kazufumi Toume; Elizabeth Luvai; Khine Mya Nwe; Shusaku Mizukami; Kenji Hirayama; Katsuko Komatsu; Kouichi Morita
Journal:  J Nat Med       Date:  2022-01-10       Impact factor: 3.192

Review 3.  Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight.

Authors:  Dheeraj Bisht; Mohmmad Rashid; Rajeshwar Kamal Kant Arya; Deepak Kumar; Sushil Kumar Chaudhary; Vijay Singh Rana; Neeraj K Sethiya
Journal:  Phytomed Plus       Date:  2021-12-18

4.  Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial.

Authors:  Adel A Gomaa; Hamdy S Mohamed; Rasha B Abd-Ellatief; Mohamed A Gomaa; Doaa S Hammam
Journal:  Inflammopharmacology       Date:  2022-03-01       Impact factor: 4.473

5.  Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3.

Authors:  Weikang Luo; Ruoqi Ding; Xiaohang Guo; Tao Zhan; Tao Tang; Rong Fan; Yang Wang
Journal:  Comput Biol Med       Date:  2022-03-26       Impact factor: 6.698

6.  Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation.

Authors:  Jun-Feng Cao; Yunli Gong; Mei Wu; Xingyu Yang; Li Xiong; Shengyan Chen; Zixuan Xiao; Yang Li; Lixin Zhang; Wang Zan; Xiao Zhang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

Review 7.  Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment.

Authors:  Adel A Gomaa; Yasmin A Abdel-Wadood; Mohamed A Gomaa
Journal:  Inflammopharmacology       Date:  2022-09-22       Impact factor: 5.093

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.